Clinical Trial Update: Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating K-877 for severe hypertriglyceridemia with renal impairment has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• K-877 (pemafibrate)

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: COMPLETED | Results posted: 2022-10-28